drugset / Trial / NCT03452917
Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
Phase 2/3
Completed
1502 enrolled
University of Washington
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In this clinical study, a total of 1500 patients with out-of-hospital cardiac arrest in Seattle/King County will be enrolled. This will be a randomized clinical trial and patients will receive either two different doses of IV sodium nitrite (45 mg or 60 mg) or placebo during resuscitation in the field by paramedics. The primary outcome will be proportion of patients surviving to hospital admission.
Timeline
- Start
- 2018-02-08
- Primary completion
- 2019-12-31
- Completion
- 2020-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Nitrite | Small molecule | 45 mg | Intravenous |
| Subject | Sodium Nitrite | Small molecule | 60 mg | Intravenous |